A 35-year-old male construction worker from rural Maharashtra presents to a primary health centre with a 3-week history of productive cough with blood-tinged sputum, fever, and night sweats. On examination, he appears cachectic with crackles in the right upper lobe. Chest X-ray shows a cavitary lesion in the right upper lobe. Sputum smear microscopy (ZN staining) is positive for acid-fast bacilli (AFB) on the first smear itself. According to RNTCP guidelines, what is the most appropriate next step in management?

Explanation

## RNTCP Management of Smear-Positive TB **Key Point:** A smear-positive TB patient with clinical and radiological evidence of TB should be started on standard first-line anti-TB therapy immediately without waiting for culture or DST results, as per RNTCP guidelines. ### Rationale for Correct Answer This patient has: - Smear-positive TB (AFB positive on first smear) - Classic clinical presentation (productive cough, haemoptysis, fever, night sweats, weight loss) - Radiological evidence of pulmonary TB (cavitary lesion, upper lobe) **High-Yield:** RNTCP recommends immediate initiation of Category 1 regimen (HRZE for 2 months + HR for 4 months) in all smear-positive TB cases without delay. Waiting for DST or culture confirmation is NOT recommended for initial treatment in resource-limited settings, as it delays therapy and increases transmission. ### Standard RNTCP Regimen for New TB Cases | Phase | Duration | Drugs | Frequency | |-------|----------|-------|----------| | Intensive | 2 months | HRZE | Daily (DOT) | | Continuation | 4 months | HR | Thrice weekly (DOT) | **Clinical Pearl:** The RNTCP operates on a "treat-all-smear-positive" principle to reduce transmission and improve outcomes in high-burden TB settings. Bacteriological confirmation (smear positivity) is sufficient to start treatment. ### DOT Strategy **Key Point:** DOT can be initiated at the PHC/sub-centre level itself; admission to a TB unit is NOT mandatory for uncomplicated cases. The emphasis is on community-based DOT to ensure adherence and reduce default rates. ## Why Immediate Treatment is Critical 1. Smear-positive patients are infectious and pose public health risk 2. Early treatment reduces transmission and improves individual cure rates 3. RNTCP guidelines prioritize rapid diagnosis and treatment initiation 4. Delay in treatment increases mortality and morbidity [cite:RNTCP Guidelines 2023, Park 26e Ch 8]